2012Ultrasound in Obstetrics and GynecologyOpen access

P09.23: A clinical trial of ultrasound treatment for TRAP sequence

Kiyotake Ichizuka, Junichi Hasegawa, Masamitsu Nakamura, Ryu Matsuoka, Akihiko Sekizawa, Takashi Okai, S. Umemura

Open full text 1 citations

Abstract

We present a case of TRAP sequence for which high-intensity focused ultrasound (HIFU) was applied as a non-invasive fetal therapy. Case; A 23-year-old woman was admitted to our hospital at 22 gestational weeks. Ultrasonography led to a diagnosis of TRAP sequence. Neither hydramnios nor signs of heart failure were identified in the normal fetus, but because the anomalous fetus displayed pronounced subcutaneous edema, the decision was made at 26 gestational week to apply ultrasound-guided HIFU exposure to occlude the vessel and interrupt the blood flow of the anomalous fetus. The Ethics Committee for Clinical Studies approved the procedure and consent was obtained from the patient after explanation. Target for HIFU exposure was the internal blood flow at the point where the umbilical cord entered the body of the anomalous fetus. Exposure was performed multiple times and decreased blood flow was confirmed by Doppler color imaging; however, complete occlusion was not achieved. Despite the failure of complete occlusion, a hyperechoic area was observed just proximal to the target blood; this finding indicated degeneration of the tissue by exposure to HIFU. Collateral damage was not seen in either the pump fetus or the mother's body. Polyhydramnios appeared at 29 gestational weeks, thus making premature birth an imminent threat. Therefore, a cesarean section was performed. The pump fetus weighed 845 g, the anomalous fetus weighed 2800 g. After 9 months, the survival baby does not have severe clinical complication and mother does not have any complications. The concept of the present treatment using HIFU does not involve insertion of a device into the uterus and enables thermal denaturation of the fetal tissue without any direct fetal contact. Although the procedure was not completely successful in this case, the possibility of inducing localized denaturation of human fetal tissue has been demonstrated, thus marking a step toward the future use of HIFU in fetal treatment.

Open-access reader

About this research paper

What this paper is about

We present a case of TRAP sequence for which high-intensity focused ultrasound (HIFU) was applied as a non-invasive fetal therapy. Case; A 23-year-old woman was admitted to our hospital at 22 gestational weeks. Ultrasonography led to a diagnosis of TRAP sequence. Neither hydramnios nor signs of heart failure were identified in the normal fetus, but because the anomalous fetus displayed pronounced subcutaneous edema, the decision was made at 26 gestational week to apply ultrasound-guided HIFU exposure to occlude the vessel and interrupt the blood flow of the anomalous fetus. The Ethics Committee for Clinical Studies approved the procedure and consent was obtained from the patient after explanation. Target for HIFU exposure was the internal blood flow at the point where the umbilical cord entered the body of the anomalous fetus. Exposure was performed multiple times and decreased blood flow was confirmed by Doppler color imaging; however, complete occlusion was not achieved. Despite the failure of complete occlusion, a hyperechoic area was observed just proximal to the target blood; this finding indicated degeneration of the tissue by exposure to HIFU. Collateral damage was not seen in either the pump fetus or the mother's body. Polyhydramnios appeared at 29 gestational weeks, thus making premature birth an imminent threat. Therefore, a cesarean section was performed. The pump fetus weighed 845 g, the anomalous fetus weighed 2800 g. After 9 months, the survival baby does not have severe clinical complication and mother does not have any complications. The concept of the present treatment using HIFU does not involve insertion of a device into the uterus and enables thermal denaturation of the fetal tissue without any direct fetal contact. Although the procedure was not completely successful in this case, the possibility of inducing localized denaturation of human fetal tissue has been demonstrated, thus marking a step toward the future use of HIFU in fetal treatment.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We present a case of TRAP sequence for which high-intensity focused ultrasound (HIFU) was applied as a non-invasive fetal therapy. Case; A 23-year-old woman was admitted to our hospital at 22 gestational weeks. Ultrasonography led to a diagnosis of TRAP sequence. Neither hydramnios nor signs of heart failure were identified in the normal fetus, but because the anomalous fetus displayed pronounced subcutaneous edema, the decision was made at 26 gestational week to apply ultrasound-guided HIFU exposure to occlude the vessel and interrupt the blood flow of the anomalous fetus. The Ethics Committee for Clinical Studies approved the procedure and consent was obtained from the patient after explanation. Target for HIFU exposure was the internal blood flow at the point where the umbilical cord entered the body of the anomalous fetus. Exposure was performed multiple times and decreased blood flow was confirmed by Doppler color imaging; however, complete occlusion was not achieved. Despite the failure of complete occlusion, a hyperechoic area was observed just proximal to the target blood; this finding indicated degeneration of the tissue by exposure to HIFU. Collateral damage was not seen in either the pump fetus or the mother's body. Polyhydramnios appeared at 29 gestational weeks, thus making premature birth an imminent threat. Therefore, a cesarean section was performed. The pump fetus weighed 845 g, the anomalous fetus weighed 2800 g. After 9 months, the survival baby does not have severe clinical complication and mother does not have any complications. The concept of the present treatment using HIFU does not involve insertion of a device into the uterus and enables thermal denaturation of the fetal tissue without any direct fetal contact. Although the procedure was not completely successful in this case, the possibility of inducing localized denaturation of human fetal tissue has been demonstrated, thus marking a step toward the future use of HIFU in fetal treatment.

Key concepts: Medicine, Fetus, Polyhydramnios, Complication, Gestational age, Ultrasound, Surgery, Obstetrics

Related papers

Back to paper searchBrowse research topicsOriginal source
P09.23: A clinical trial of ultrasound treatment for TRAP sequence — Research Paper | ScholarLens